Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Hasan Al-Sayegh
Deciphering Urogenital Cancers through Proteomic Biomarkers: A Systematic Review and Meta-Analysis
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Building a Harmonized Datamart by Integrating Cross-Institutional Systems of Clinical, Outcome, and Genomic Data: The Pediatric Patient Informatics Platform (PPIP) | JCO Clinical Cancer Informatics
PURPOSE Siloed electronic medical data limits utility and accessibility. At the Dana-Farber/Boston Children's Cancer and Blood Disorders Center, cross-institutional data were inconsistent and difficult to access. To unify data for clinical operations, administration, and research, we developed the Pediatric Patient Informatics Platform (PPIP), an integrated datamart harmonizing multiple source systems across two institutions into a common technology.
Parental Considerations Regarding Cure and Late Effects for Children With Cancer
Abstract BACKGROUND: More than 80% of children with cancer become long-term survivors, yet most survivors experience late effects of treatment. Little is known about how parents and physicians consider late-effects risks against a potential survival benefit when making treatment decisions. METHODS: We used a discrete choice experiment to assess the importance of late effects on treatment decision-making and acceptable trade-offs between late-effects risks and survival benefit.
Parental Considerations Regarding Cure and Late Effects for Children With Cancer
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00 Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
Provider Perspectives on Use of Medical Marijuana in Children With Cancer
Sign up for Insight Alerts highlighting editor-chosen studies with the greatest impact on clinical care. See the Pediatrics Best Articles of 2017, with video recaps. Due to the popularity of the AAP Virtual Career Fair, there's a new Winter event Wednesday, January 31 through Thursday, February 1. Registration is free to all job seekers; sign up now.
Provider Perspectives on Use of Medical Marijuana in Children With Cancer
Provider Perspectives on Use of Medical Marijuana in Children With Cancer Prasanna Ananth, Clement Ma, Hasan Al-Sayegh, Leah Kroon, Victoria Klein, Claire Wharton, Elise Hallez, Ilana Braun, Kelly Michelson, Abby R. Rosenberg, Wendy London, Joanne Wolfe Pediatrics Dec 2017, e20170559; DOI: 10.1542/peds.2017-0559
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Hasan
Contact Hasan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack